This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20140521 PLA call"
Jump to navigation
Jump to search
(Created page with "{{subst::PLA Template}}") |
|||
| Line 13: | Line 13: | ||
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | | colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | ||
'''Location: ''' Phone: +1 770-657-9270, Participant Code: 985371, <br/>https://global.gotomeeting.com/join/111567781 | '''Location: ''' Phone: +1 770-657-9270, Participant Code: 985371, <br/>https://global.gotomeeting.com/join/111567781 | ||
| − | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2014- | + | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2014-05-21'''<br/> '''Time: 2PM''' |
|- | |- | ||
| colspan="1" align="right"|'''Facilitator''' | | colspan="1" align="right"|'''Facilitator''' | ||
| − | | colspan="1" align="left"|Mary Kay | + | | colspan="1" align="left"|Mary Kay |
| colspan="1" align="right"|'''Note taker(s)''' | | colspan="1" align="right"|'''Note taker(s)''' | ||
| colspan="1" align="left"| Lynn | | colspan="1" align="left"| Lynn | ||
| Line 26: | Line 26: | ||
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee''' | | border="1" cellpadding="2" colspan="1" align="left"|'''Attendee''' | ||
| '''Name''' | | '''Name''' | ||
| − | |||
| − | |||
<!---============================================================================== | <!---============================================================================== | ||
| | | | | | ||
| Line 85: | Line 83: | ||
===Agenda=== | ===Agenda=== | ||
Agenda review | Agenda review | ||
| − | *Notes of [[ | + | *Notes of [[20140507_PLA_Meeting]] review |
| − | * | + | *Take a single product family and describe the governance structure for V2 and its IG for example. |
**Level of granularity | **Level of granularity | ||
**Identify which pieces are orphaned, and the political elements to be surfaced. | **Identify which pieces are orphaned, and the political elements to be surfaced. | ||
| Line 93: | Line 91: | ||
**Governance on V2.x (v2.9 substantive changes) | **Governance on V2.x (v2.9 substantive changes) | ||
**develop form to request establishing a Product Family | **develop form to request establishing a Product Family | ||
| + | *Project Services noticed we currently have 19 projects with “New Product Definition”. | ||
| Line 128: | Line 127: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
| − | *[[ | + | *[[20140528 PLA call]] |
|} | |} | ||
© 2014 Health Level Seven® International. All rights reserved | © 2014 Health Level Seven® International. All rights reserved | ||
Revision as of 15:53, 16 May 2014
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2014-05-21 Time: 2PM | ||
| Facilitator | Mary Kay | Note taker(s) | Lynn |
| Attendee | Name | ||
| Calvin Beebe | |||
| Woody Beeler | |||
| Lorraine Constable | |||
| Bo Dagnall | |||
| Jean Duteau, | |||
| Rick Haddorff | |||
| Tony Julian | |||
| Paul Knapp | |||
| Austin Kreisler, | |||
| Lynn Laakso | |||
| Mary Kay McDaniel | |||
| Brian Pech | |||
| John Quinn | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20140507_PLA_Meeting review
- Take a single product family and describe the governance structure for V2 and its IG for example.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
- Project Services noticed we currently have 19 projects with “New Product Definition”.
Minutes
Convened
Adjourned
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2014 Health Level Seven® International. All rights reserved
